Pluristem Therapeutc (PSTI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.0000 -0.0300 (-2.91%) 07/25/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0000 unch (unch) -
for Mon, Jul 25th, 2022
Results
download Want to compare other data? Select FieldsSymbol | PSTI | AZN | AMGN | GILD | VRTX |
Company | Pluristem Therapeutc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 1.0200 | 72.43 | 306.22 | 110.00 | 498.59 |
High | 1.0500 | 73.04 | 307.57 | 111.81 | 506.54 |
Low | 0.9500 | 72.37 | 304.29 | 109.74 | 498.59 |
Last | 1.0000 | 72.84 | 305.77 | 111.16 | 502.55 |
Change | -0.0300 | +0.12 | +0.06 | +1.89 | +2.27 |
% Change | -2.91% | +0.17% | +0.02% | +1.73% | +0.45% |
Volume | 170,600 | 4,563,200 | 1,736,900 | 6,383,200 | 1,233,800 |
20-Day Average Volume | 86,285 | 5,764,380 | 3,114,760 | 10,958,785 | 1,399,150 |
Previous Close | 1.0300 | 72.72 | 305.71 | 109.27 | 500.28 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.1591 | 75.87 | 314.54 | 112.12 | 499.10 |
20-Day Raw Stochastic | 12.20% | 15.61% | 6.98% | 42.33% | 62.49% |
20-Day Relative Strength | 35.91% | 45.43% | 50.23% | 57.44% | 57.95% |
Weighted Alpha | -71.40 | +3.98 | +6.14 | +60.28 | +20.36 |
Today's Opinion | 100% Sell | 8% Sell | 16% Buy | 80% Buy | 88% Buy |
Previous Opinion | 100% Sell | 24% Sell | 16% Buy | 80% Buy | 88% Buy |
Last Month's Opinion | 100% Sell | 24% Buy | 24% Buy | 100% Buy | 40% Buy |
Performance | |||||
5-Days | |||||
%Chg | -6.27% since 07/18/22 | -4.81% since 03/20/25 | -2.94% since 03/20/25 | +5.00% since 03/20/25 | -1.50% since 03/20/25 |
Low | 0.9500 on 07/25/22 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.92 on 03/21/25 | 497.78 on 03/26/25 |
High | 1.1100 on 07/20/22 | 75.90 on 03/21/25 | 317.58 on 03/24/25 | 111.81 on 03/27/25 | 513.97 on 03/24/25 |
1-Month | |||||
%Chg | -21.26% since 06/24/22 | -3.71% since 02/27/25 | -0.02% since 02/27/25 | -0.74% since 02/27/25 | +5.91% since 02/27/25 |
Low | 0.9500 on 07/25/22 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.70 on 03/20/25 | 474.01 on 02/28/25 |
High | 1.3600 on 07/08/22 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | -42.53% since 04/25/22 | +9.93% since 12/27/24 | +16.42% since 12/27/24 | +18.12% since 12/27/24 | +22.94% since 12/27/24 |
Low | 0.9500 on 07/25/22 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 397.24 on 01/13/25 |
High | 1.7800 on 04/26/22 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | -34.21% since 01/25/22 | -6.16% since 09/27/24 | -5.24% since 09/27/24 | +32.95% since 09/27/24 | +8.57% since 09/27/24 |
Low | 0.9500 on 07/25/22 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
High | 2.2100 on 03/24/22 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 32,348 | 225,892,416 | 164,261,168 | 138,432,656 | 129,049,824 |
Shares Outstanding, K | 32,348 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -49,870,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | 230,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | -9,860,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | 1.91 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | -0.31 on 05/09/22 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 09/12/22 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 17.69 | 15.42 | 23.70 | 0.00 |